Evaluation of the application of nocturnal nasal continuous positive airway pressure (CPAP) in the treatment of obstructive sleep apnea
Roche N, Durieux P
Record ID 31995000094
To assess the efficacy of CPAP at the request of French National Health Insurance.
Authors' results and conclusions: Treatment by nasal Continuous Positive Airway Pressure (CPAP) is currently considered to be the reference treatment for sleep obstructive apnea. Other treatments (surgical treatments, medications) are less effective. However, no controlled studies of CPAP are available and the follow-up of patients does not exceed 3 years. The efficacy of treatment on mortality and complications has not been clearly documented.
Authors' recommendations: CPAP is recommended for obstructive sleep apnea syndrome only when the diagnosis is confirmed by nocturnal polygraphic or poly omnographic examination. Compliance with treatment must be assessed by the prescriber. Further research is required concerning the natural history of the disease and the influence of treatment on its course and simpler diagnostic tests need to be developed.
Authors' methods: Systematic review
Project Status: Completed
URL for project: http://www.has-sante.fr/
Year Published: 1992
English language abstract: An English language summary is available
Publication Type: Not Assigned
- Positive-Pressure Respiration
- Sleep Apnea Syndromes
Organisation Name: L'Agence Nationale d'Accreditation d'Evaluation en Santé
Contact Address: 2 avenue du Stade de France, 93218 Saint-Denis La Plaine Cedex, France. Tel: +33 01 55 93 71 88; Fax: +33 01 55 93 74 35;
Contact Name: firstname.lastname@example.org
Contact Email: email@example.com
Copyright: Agence Nationale pour le Developpement de l'Evaluation Medicale
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.